For General Information, page-1114

No I want it to succeed. I don’t treat HC like a marketing notice board like you seem to do however (perhaps that’s my HC greenhorn naivety).

ANP was set up as an interesting experiment by Circadian and Ionis. The travesty would be if a possibly ground-breaking drug (ATL1102) didn’t make it to market because the pint-sized ANP couldn’t raise enough funds to successfully commercialise it (whereas Ionis may have).

I can’t work out if the management have done well to get this far, or whether they have dropped the ball and created a corporate history of not getting very far, that dissuades future insto investment.

Lets hope a successful trial result leads to a positive outcome. I’m not sure I’ll be there though.